Inhibitory effect of pregnancy on counterregulatory hormone responses to hypoglycemia in awake rat.
Intensive insulin treatment during diabetic pregnancy is complicated by maternal hypoglycemia. To investigate whether pregnancy may contribute as an independent hypoglycemia risk factor, awake pregnant rats that were near term underwent stepped insulin hypoglycemic (3.4 and 2.3 mM) clamp studies in the fasted and nonfasted states. In the fasted state, the glucagon response to hypoglycemia was completely suppressed in the pregnant rats (P < 0.01). Epinephrine, but not norepinephrine, was also diminished by approximately 70-75% at both hypoglycemic steps, and more exogenous glucose was needed to maintain hypoglycemia during pregnancy. To avoid the potential confounding effect of increased ketone levels (beta-hydroxybutyrate was approximately 170% higher in the pregnant rats), experiments were repeated in the nonfasting state when ketosis was eliminated in both groups. The nonfasted pregnant rats continued to show near complete suppression of the glucagon response, even at glucose levels of 2.3 mM. In contrast, a brisk response occurred in nonpregnant controls when glucose fell to 3.4 mM. Although epinephrine levels in the pregnant rats were also markedly suppressed during the milder hypoglycemic stimulus, they approached values seen in nonpregnant controls when glucose was lowered further to 2.3 mM. We concluded that in the rat, pregnancy markedly suppresses glucagon responses to hypoglycemia. The release of epinephrine, but not norepinephrine, is also blunted, especially during mild hypoglycemia. These findings suggest that pregnancy may impair glucose counterregulation by inhibiting glucagon and epinephrine release during hypoglycemia.
Rossi
G
G
Department of Internal Medicine/Endocrinology, Yale University School of Medicine, New Haven, CT 06510.
Lapaczewski
P
P
Diamond
M P
MP
Jacob
R J
RJ
Shulman
G I
GI
Sherwin
R S
RS
D020155:3-Hydroxybutyric Acid; D000704:Analysis of Variance; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D004837:Epinephrine / Q000097:blood*; D005215:Fasting; D005260:Female; D005934:Glucagon / Q000097:blood*; D006885:Hydroxybutyrates / Q000097:blood; D007003:Hypoglycemia / Q000097:blood* / Q000139:chemically induced / Q000503:physiopathology*; D007328:Insulin / Q000009:adverse effects; D007333:Insulin Resistance / Q000502:physiology; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000097:blood / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D001786:Blood Glucose; D006885:Hydroxybutyrates; D007328:Insulin; D005934:Glucagon; D020155:3-Hydroxybutyric Acid; D004837:Epinephrine